Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker GMED
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | James R. Tobin Director | GMED Globus Medical, Inc. | 41,666 | $3.1M | — | Nov 10, 2026 | Form 4 ↗ 2 days later · 41,666 shares | Form 144 ↗ |
| Nov 4, 2026 | Ann D. Rhoads Director | GMED Globus Medical, Inc. | 5,000 | $425.0K | 10b5-1 | Nov 4, 2026 | Form 4 ↗ 1 day later · 5,000 shares | Form 144 ↗ |
| Sep 15, 2026 | James R. Tobin Director | GMED Globus Medical, Inc. | 30,000 | $2.2M | — | Sep 15, 2026 | Form 4 ↗ 1 day later · 30,000 shares | Form 144 ↗ |
| Aug 18, 2026 | Stephen T. Zarrilli Director | GMED Globus Medical, Inc. | 25,000 | $2.2M | — | Aug 18, 2026 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| Jun 5, 2026 | David D. Davidar Director | GMED Globus Medical, Inc. | 25,000 | $2.0M | — | Jun 5, 2026 | Form 4 ↗ 4 days later · 25,000 shares | Form 144 ↗ |
| Apr 14, 2026 | John A. DeFord Former Director | GMED Globus Medical, Inc. | 30,000 | $2.8M | — | Apr 14, 2026 | — | Form 144 ↗ |
| Feb 25, 2026 | Huller Kelly Officer | GMED Globus Medical, Inc. | 20,000 | $1.9M | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 2 days later · 20,000 shares | Form 144 ↗ |
| Feb 12, 2026 | Huller Kelly Officer | GMED Globus Medical, Inc. | 10,000 | $876.0K | 10b5-1 | Feb 12, 2026 | Form 4 ↗ 5 days later · 10,000 shares | Form 144 ↗ |
| Jan 8, 2026 | Kyle Kline Officer | GMED Globus Medical, Inc. | 3,594 | $363.2K | 10b5-1 | Jan 8, 2026 | Form 4 ↗ 4 days later · 3,594 shares | Form 144 ↗ |
| Jan 8, 2026 | Leslie V. Norwalk Director | GMED Globus Medical, Inc. | 2,000 | $202.0K | 10b5-1 | Jan 8, 2026 | Form 4 ↗ 4 days later · 2,000 shares | Form 144 ↗ |
| Dec 12, 2025 | Leslie V. Norwalk Director | GMED Globus Medical, Inc. | 4,000 | $355.0K | 10b5-1 | Dec 12, 2025 | Form 4 ↗ 4 days later · 4,000 shares | Form 144 ↗ |
| Dec 1, 2025 | Kyle Kline Officer | GMED Globus Medical, Inc. | 18,542 | $1.7M | 10b5-1 | Dec 1, 2025 | Form 4 ↗ 2 days later · 18,542 shares | Form 144 ↗ |
| Nov 25, 2025 | Huller Kelly Officer | GMED Globus Medical, Inc. | 7,500 | $675.0K | 10b5-1 | Nov 25, 2025 | Form 4 ↗ 3 days later · 7,500 shares | Form 144 ↗ |
| Nov 12, 2025 | David D. Davidar Director | GMED Globus Medical, Inc. | 25,000 | $2.1M | — | Nov 12, 2025 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| Nov 12, 2025 | Stephen T. Zarrilli Director | GMED Globus Medical, Inc. | 25,000 | $2.1M | — | Nov 11, 2025 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| Nov 10, 2025 | Ann D. Rhoads Director | GMED Globus Medical, Inc. | 2,000 | $170.0K | 10b5-1 | Nov 10, 2025 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Nov 7, 2025 | Ann D. Rhoads Director | GMED Globus Medical, Inc. | 8,000 | $647.7K | 10b5-1 | Nov 7, 2025 | Form 4 ↗ 3 days later · 10,000 shares | Form 144 ↗ |
| Sep 15, 2025 | Ann D. Rhoads Director | GMED Globus Medical, Inc. | 10,000 | $584.0K | 10b5-1 | Sep 15, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Feb 28, 2025 | Ann D. Rhoads Director | GMED Globus Medical, Inc. | 7,500 | $590.0K | 10b5-1 | Feb 28, 2025 | Form 4 ↗ 4 days later · 7,500 shares | Form 144 ↗ |
| Jan 10, 2025 | Keith W. Pfeil Officer | GMED Globus Medical, Inc. | 14,167 | $1.3M | 10b5-1 | Jan 10, 2025 | Form 4 ↗ 4 days later · 14,167 shares | Form 144 ↗ |
| Dec 2, 2024 | Huller Kelly Officer | GMED Globus Medical, Inc. | 2,500 | $217.4K | 10b5-1 | Dec 2, 2024 | Form 4 ↗ 2 days later · 2,500 shares | Form 144 ↗ |
| Nov 21, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 20,000 | $1.7M | 10b5-1 | Nov 21, 2024 | Form 4 ↗ 4 days later · 40,000 shares | Form 144 ↗ |
| Nov 21, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 20,000 | $17.0K | 10b5-1 | Nov 21, 2024 | Form 4 ↗ 4 days later · 40,000 shares | Form 144 ↗ |
| Nov 21, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 3,500 | $297.3K | 10b5-1 | Nov 21, 2024 | Form 4 ↗ 4 days later · 40,000 shares | Form 144 ↗ |
| Nov 21, 2024 | Dan Lemaitre Director | GMED Globus Medical, Inc. | 14,375 | $1.2M | — | Nov 21, 2024 | Form 4 ↗ 4 days later · 14,375 shares | Form 144 ↗ |
| Nov 21, 2024 | Daniel T. Scavilla Officer | GMED Globus Medical, Inc. | 130,000 | $11.0M | 10b5-1 | Nov 21, 2024 | Form 4 ↗ 4 days later · 130,000 shares | Form 144 ↗ |
| Nov 6, 2024 | Daniel T. Scavilla Officer, Director | GMED Globus Medical, Inc. | 60,000 | $4.8M | 10b5-1 | Nov 6, 2024 | Form 4 ↗ 2 days later · 60,000 shares | Form 144 ↗ |
| Nov 6, 2024 | Huller Kelly Officer | GMED Globus Medical, Inc. | 5,000 | $405.0K | 10b5-1 | Nov 6, 2024 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Oct 16, 2024 | Huller Kelly Officer | GMED Globus Medical, Inc. | 7,500 | $562.3K | 10b5-1 | Oct 16, 2024 | Form 4 ↗ 2 days later · 7,500 shares | Form 144 ↗ |
| Oct 16, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 3,500 | $262.4K | 10b5-1 | Oct 16, 2024 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| Oct 16, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 20,000 | $1.5M | 10b5-1 | Oct 16, 2024 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| Oct 16, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 30,000 | $2.3M | 10b5-1 | Oct 16, 2024 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| Sep 13, 2024 | Ann D. Rhoads Director | GMED Globus Medical, Inc. | 15,000 | $1.1M | — | Sep 13, 2024 | — | Form 144 ↗ |
| Sep 13, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 25,000 | $1.8M | — | Sep 13, 2024 | Form 4 ↗ 35 days later · 50,000 shares | Form 144 ↗ |
| Jul 11, 2024 | Leslie V. Norwalk Director | GMED Globus Medical, Inc. | 1,000 | $70.0K | 10b5-1 | Jul 11, 2024 | — | Form 144 ↗ |
| May 10, 2024 | Dan Lemaitre Director | GMED Globus Medical, Inc. | 52,500 | $3.4M | — | May 10, 2024 | — | Form 144 ↗ |
| May 10, 2024 | Dan Lemaitre Director | GMED Globus Medical, Inc. | 10,800 | $693.8K | — | May 10, 2024 | — | Form 144 ↗ |
| May 8, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 3,500 | $227.3K | — | May 8, 2024 | — | Form 144 ↗ |
| May 8, 2024 | David D. Davidar Director | GMED Globus Medical, Inc. | 20,000 | $1.3M | 10b5-1 | May 8, 2024 | — | Form 144 ↗ |
| Mar 15, 2024 | Leslie V. Norwalk Director | GMED Globus Medical, Inc. | 10,590 | $550.0K | 10b5-1 | Mar 15, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Huller Kelly Officer | GMED Globus Medical, Inc. | 7,500 | $405.3K | — | Mar 1, 2024 | — | Form 144 ↗ |
| May 16, 2023 | Dan Lemaitre Director | GMED Globus Medical, Inc. | 43,450 | $2.5M | — | May 15, 2023 | — | Form 144 ↗ |
42 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:25 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances